ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors

  • Leading medical oncologist and seasoned biotechnology executive with significant experience in drug development

 Barcelona, Spain, 23 May 2023: ONA Therapeutics (“ONA”), which is specialized in unravelling novel biology to design biopharmaceuticals attacking advanced cancer, is pleased to announce the appointment of Dr. Pamela Klein as independent member to its board of directors.

Read more…